Dr. Reddy’s is launching doxercalciferol injection, in 4 mcg/2 mL multidose vials. The product is the generic of Sanofi-Aventis’ Hectorol (doxercalciferol) injection 4 mcg/2 mL (2 mcg/mL) ...

Lupin’s Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vial is the generic version of Genzyme’s Hectorol Injection. It is indicated for the treatment of secondary hyperparathyroidism in ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

CINCINNATI — Prasco Laboratories announced on Tuesday that it has started shipping the generic version of Hectorol (doxercalciferol) 0.5-, 1.0- and 2.5-mcg capsules, each in 50-count bottles under the ...

Drug firm Lupin on Monday said it has received approval from the US health regulator to market its generic Doxercalciferol injection in the American market. The company has received approval from the ...

Doxercalciferol 2mcg/mL; soln for IV inj. Give by IV bolus inj. Dialysis: initially 4mcg three times weekly after dialysis; titrate dose to maintain desired iPTH therapeutic range and serum calcium ...

Dr. Reddy’s Laboratories (DRL) has launched Doxercalciferol injection, 4 mcg/2 mL (2 mcg/mL) multiple-dose vials, in the U.S. market. A therapeutic generic equivalent of Hectorol (doxercalciferol) ...

Review the side-effects of Doxercalciferol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

New Report Added in ResearchMoz Reports Database Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic ...

Dr Reddy’s Laboratories Ltd has launched Doxercalciferol injection in the US market. It is the therapeutic generic equivalent of Hectorol (doxercalciferol) injection approved by the US Food and Drug ...